In response to COVID-19 pandemic, BIPAI has organized a weekly clinical lead forum with experts from our global network, including our Global Health Corps and Texas Children's Hospital physicians, reviewing emerging literature and case studies to promote the exchange of effective clinical strategies, best practices, and lessons learned.

Note: The date of the presentation is listed. Due to the evolving nature of the COVID-19 pandemic, the information presented may be outdated or no longer applicable due to new evidence. 

1. Topic: COVID-19 Overview

Speaker: Heather Haq, MD, MHS

Date: 03/27/20

Description: The presentation provides a high-level overview of COVID-19 clinical information relevant to BIPAI network sites, with focus on virus basics, transmission, and clinical features.

2. Topic: Infection Control

Speaker: Amy Benson, MD

Date: 04/03/20

Description: The presentation provides an overview of infection control, personal protective equipment, triage, and adapted work practices to limit exposure.

3. Topic: Self Care and Coping in the Healthcare Provider

Speaker: Gia Washington, PhD, ABPP

Date: 04/17/20

Description: The presentation reviews the dimensions of wellness and factors that can contribute to occupational stress and shares ways individuals can promote positive thinking.

4. Topic: Novel Therapies for COVID-19

Speaker: Jason Choi, MD; Brigid O’Brien, DO MS

Date: 04/24/20

Description: The presentation provides guidance on how to evaluate evidence and reviews novel therapies for COVID-19, particularly the ones that have gotten attention in the press.

5. Topic: COVID-19 and Diagnostics

Speaker: Francesca Basile, MD

Date: 05/15/20

Description: The presentation discusses useful concepts in clinical virology, laboratory diagnosis of COVID-19, ramping up testing capacity in Africa, and testing as an exit strategy for COVID-19 pandemic.

6. Topic: Acute COVID-19 Management

Speaker: Jaime Petrus, MD

Date: 05/22/20

Description: The presentation uses two case studies to help prepare for the acute management of moderate or severe COVID-19 patients in the clinic with limited or delayed referral capacity, review current understanding of pulmonary pathophysiology in COVID-19 disease, and discuss options to possibly forestall intubation and basic ventilation strategy.

7. Topic: COVID-19: Pediatric Considerations in the Resource Constrained Setting

Speaker: Liane Campbell, MD

Date: 05/29/20

Description: The presentation discusses the clinical presentation of COVID-19 in children, characteristics of Multi-system inflammatory syndrome in children (MIS-C), considerations where COVID-19 testing is limited, and the secondary impact of pandemic on children globally.

8. Topic: Tuberculosis (TB) and COVID-19 Intersection

Speaker: Alexander Kay, MD

Date: 06/05/20

Description: The presentation reviews Global TB and COVID-19 epidemiology and the co-morbidity of the two diseases, and outlines areas of programming overlap and how to maintain TB services during the pandemic. The presentation also discusses the BCG vaccination’s role in preventing TB and the current evidence around its prevention of COVID-19.

To learn more about Baylor College of Medicine and Texas Children’s Hospital’s Global TB Program, which is a BIPAI affiliate, click here.

9. Topic: How can we address the risks to young people during the COVID-19 pandemic?

Speaker: Dr. Kajal Hirani, FRACP, MBBS, BSc, DTM&H

Date: 06/12/20

Description: The presentation highlights the risks to young people living with HIV during the COVID-19 pandemic, discusses the measures implemented at various BIPAI sites to mitigate risks, and provides recommendations to improve health care provision to young people. 

10. Topic: COVID-19 Pathophysiology

Speaker: Kevin McKenzie, MD, MSPH
Date: 06/19/20
Description: The presentation shares new resources on COVID-19 and provides background on the pathophysiology of COVID-19 with a focus on ACE2, ARDS, lung injury, Thrombosis, kidneys, and other effects. 
Credit: Virus electron micrographs provided by NIAID-RML.

11. Topic: COVID-19 and Pregnancy

Speaker: Abida Hasan, MD 
Date: 06/26/20
Description: The presentation reviews COVID-19 and pregnancy, including clinical presentation, clinical management, the effects of pregnancy on COVID-19, the effects of COVID-19 on pregnancy, and special considerations for pregnancy. The presentation also highlights successful COVID-19 management strategies implemented by the Texas Children's Global Women's Health team in Llongwe, Malawi. 
To learn more about Texas Children’s Global Women’s Health program, click here.
Speaker: Maria Elena Bottazzi, PhD 
Date: 07/17/20
Description: The presentation reviews Neglected Tropical Diseases vaccine development over the past 20 years. It addresses the complexities of the vaccine development process and the considerations for global access to a COVID-19 vaccine. 
To learn more about Texas Children's Center for Vaccine Development, click here.

13. Topic: COVID-19 and Dermatologic Manifestations

Speaker: Drs. Mimi Abadie and Sarah Perry 

Date: 07/31/20
Description: The presentation reviews skin anatomy and highlights emerging skin manifestations of COVID-19 described in published studies. It also discusses unintended consequences of Personal Protective Equipment (PPE) and provides suggestions for preventing and treating the conditions that arise. 

14.  Topic: Nutrition and COVID-19

Speaker: Francesca Basile, MD

Date: 08/07/20

Description: The presentation discusses the impact of COVID-19 on food security and nutritional status and vice versa and provides diet advice during COVID-19 outbreak in low income countries with special focus on micronutrient supplementation, breastfeeding if the mother is suspected to be COVID-19 positive, and additional considerations on infant and young child feeding in emergencies. It concludes with remarks and strategies for the delivery of nutritional services and care of moderate and severe active malnutrition during lockdown.

15.     Topic: Novel Therapies for COVID-19 – An Update

Speaker: Jason Choi, MD; Brigid O’Brien, DO MS

Date: 08/14/20

Description: The presentation provides an update on the new evidence that has emerged since April regarding therapies for COVID-19. It focuses on five therapies: Dexamethazone, Hydroxychloroquine (with/without Azithromycin), Lopinavir/Ritonavir, Remdesivir, and convalescent plasma.